Nadrich Accident Injury Lawyers is representing those who have developed health conditions after taking the diabetes drug Ozempic. If you or a loved one have developed any of the following conditions after taking Ozempic for diabetes or weight loss, our law firm can help you file an Ozempic lawsuit seeking compensation for medical expenses, lost wages, pain, suffering and more:
- Gastroparesis (stomach paralysis)
- Ileus or bowel obstruction
- A gallbladder disease such as cholelithiasis or cholecystitis
- Gallbladder removal
- Pulmonary embolism
- Deep vein thrombosis
- Pulmonary aspiration
- Pancreatic cancer
- Other gastrointestinal injuries
- Suicide
We are currently accepting cases involving the above conditions and the following medications:
- Ozempic
- Wegovy
- Rybelsus
- Mounjaro
- Trulicity
Nadrich Accident Injury Lawyers has been representing victims of weight loss drugs and other dangerous drugs since 1990, having recovered over $400,000,000 for clients. We have recovered countless settlements and awards for victims of dangerous drugs, including a $5,000,000 settlement for a woman who developed primary pulmonary hypertension after using the weight loss drug Fen-Phen. Our Ozempic lawsuit lawyers have the experience and expertise to recover the maximum possible compensation on your behalf.
If you can’t afford medical treatment, we can get you to a doctor who will treat your condition on a lien, meaning you won’t be charged any medical bills until your case is over. Doctors offer our clients this deal because they know about our reputation for getting great results for our clients.We offer a free case evaluation and will not charge you to handle your Ozempic case until and unless we recover financial compensation for you. Our only fee to represent you is a percentage of any recovery we obtain for you. We won’t charge you any upfront fee to handle your Ozempic case and we won’t charge you any money out of your own pocket. In other words, you will owe us absolutely nothing if we don’t win your case.
Call us today for a free consultation, text us from this page or fill out the free case evaluation form on this page if you or a loved one developed severe gastrointestinal events such as gastroparesis or ileus after taking Ozempic. You may be able to recover compensation in an Ozempic lawsuit.
Compensation Available In An Ozempic Class Action Lawsuit
Those who file Ozempic lawsuits may be able to recover financial compensation for:
Medical Expenses
If you have developed a medical condition after taking Ozempic, you may already be facing medical bills relating to that condition. You might also need further treatment of that condition, which will generate even more medical bills.
The Ozempic lawyers at Nadrich Accident Injury Lawyers can help you recover financial compensation for any medical expenses related to the condition you developed after taking Ozempic.
Lost Wages
The condition you developed after taking Ozempic could have caused you to miss time from work, whether you were too sick to work or had to take time off from work to get the condition treated.
An Ozempic attorney at Nadrich Accident Injury Lawyers can help you recover compensation for any wages your condition caused you to be unable to earn.
Loss Of Earning Capacity
The medical condition that you ended up with after using Ozempic might have caused you to be unable to work again, or unable to ever again work in the same job field.
If you’ve suffered a loss or reduction of earning capacity due to a condition you developed after taking Ozempic, the Ozempic attorneys at Nadrich Accident Injury Lawyers can help you recover compensation for this.
Pain And Suffering
The conditions that those taking Ozempic have developed can cause tremendous physical pain and mental suffering. For example, according to a CNN report, one woman who developed gastroparesis after taking Ozempic stated that “this medicine made my life hell.”
Nadrich Accident Injury Lawyers can place an accurate value on the physical pain and mental suffering caused by the condition you developed after taking Ozempic, and we make sure that you are fairly compensated for that pain and suffering.
Wrongful Death
If you have lost a loved one due to a condition which developed after taking Ozempic, we can help you recover compensation for your grieving and suffering. We can also help you recover compensation for your loved one’s funeral bills, burial costs, pain, suffering and medical bills, as well as compensation for the loss of your loved one’s household services, companionship, love and income.
Ozempic And Gastroparesis (Stomach Paralysis)
Gastroparesis is essentially paralysis of the stomach. In a healthy, functional stomach, food is propelled through the digestive tract by strong muscle contractions. However, in those with gastroparesis, the motility of the stomach is either slowed down or simply doesn’t function at all, preventing the stomach from properly emptying. There is no cure for the condition.
Semaglutide, the active ingredient in Ozempic, belongs to a class of drugs known as GLP-1 agonists. GLP-1 agonists such as Ozempic and Wegovy have been linked to gastroparesis.
In 2018, “Liraglutide-induced Acute Gastroparesis” was published in Cureus. This case report describes a man who presented with the symptoms of a gastrointestinal obstruction, including nausea, pain for a week, and abdominal distension. Imaging didn’t discover a physical obstruction cause like a tumor, and the man ended up being diagnosed with gastroparesis. Liraglutide, a GLP-1 agonist drug, was determined to be the probable cause of the condition.
In 2020, “Gastroparesis With the Initiation of Liraglutide: A Case Report” was published in Cureus. The case report describes a woman who ended up developing clinical features which suggested gastroparesis after taking liraglutide. The case report concludes that “gastroparesis can be triggered by the initiation of liraglutide.”
In 2021, “Medication-Induced Gastroparesis: A Case Report” was published in Journal of Investigative Medicine High Impact Case Reports. It describes two separate cases of gastroparesis which were induced by the GLP-1 agonists semaglutide and dulaglutide.
Gastroparesis can be a debilitating condition. According to a CNN report, one woman who developed the condition after taking Ozempic vomits multiple times per day. The woman reportedly vomits so often that she needed to take time off from her work.
Another woman in the CNN report reportedly required stomach bypass surgery to treat the gastroparesis she developed after taking Ozempic.
In addition, severe gastroparesis cases may require feeding through a jejunostomy tube, which is a tube placed through the skin of the abdomen into the midsection of the small intestine.
If you’ve developed gastroparesis after taking Ozempic, you deserve to be compensated for the potentially debilitating complications which have resulted. The manufacturers of Ozempic knew or should have known that the drug could cause gastroparesis but failed to warn about this risk. It is this failure to warn that allows us to file an Ozempic lawsuit on your behalf seeking compensation for your medical bills, pain, suffering and more.
Call us today for a free consultation if you or a loved one developed gastroparesis after taking Ozempic.
Gastroparesis Symptoms
The symptoms of gastroparesis include:
- Abdominal pain
- Nausea
- Vomiting
- Abdominal bloating
- Vomiting undigested food which was eaten just a few hours before
- Feeling full after only a few bites of food
- Blood sugar level changes
- Acid reflux
- Malnutrition and weight loss
- Lack of appetite
Ozempic And Mounjaro Lawsuit Claims Drugs Caused Gastroparesis
On August 2, 2023, a Louisiana woman filed a lawsuit in Louisiana alleging that the GLP-1 agonist drugs Ozempic and Mounjaro caused her to develop gastroparesis.
The woman claims that use of the drugs led to her experiencing a mental health crisis as well as gastroparesis symptoms such as stomach pain, severe vomiting, gastrointestinal burning, numerous hospitalizations and emergency room visits, vomiting whole food mere hours after consuming it, and teeth which fell out because of excessive vomiting.
The lawsuit alleges that the manufacturers of the drugs knew the drugs could cause gastroparesis but failed to warn about this risk. The lawsuit seeks compensation for damages including pain, suffering, healthcare costs, medical monitoring, and punitive damages for the defendants’ reckless, fraudulent, willful and wanton acts which “demonstrated a complete disregard and reckless indifference for the safety and welfare of the general public.”
Ozempic And Ileus
While GLP-1 agonists such as Ozempic have been linked with multiple conditions such as gastroparesis, gallbladder disease and biliary diseases, one condition which was actually recently added to Ozempic’s label is ileus.
On September 22, 2023, Ileus was added to Ozempic’s label as a gastrointestinal disorder which is an adverse reaction reported during postmarketing experience. As of September 28, 2023, ileus was mentioned in 33 case reports on the Food and Drug Administration’s dashboard regarding those who are taking semaglutide. Two deaths were reported.
Human intestines move food through them via muscle contractions which occur in a motion which is wave-like. These contractions are called peristalsis.
Ileus is the term for a lack of this movement. It can cause an intestinal obstruction, meaning food, liquids and gas can’t pass through. This is a serious, potentially fatal complication, as ileus can lead to tearing or perforation of the intestine, causing the contents of the bowel – which contain a lot of bacteria – to end up in your body cavity.
You deserve to be compensated for the symptoms and complications of ileus if you’ve developed the condition after taking Ozempic. While the FDA approved Ozempic in 2017, ileus wasn’t added to the label until September 2023, despite studies being published in 2020 and 2021 linking GLP-1 agonists with intestinal obstruction. The manufacturers of Ozempic should have warned about the risk of ileus associated with the drug, and you deserve to be compensated for this failure to warn.
Call us today for a free consultation if you or a loved one developed ileus after taking Ozempic. You may be eligible for financial compensation in an Ozempic lawsuit.
Ileus Symptoms
The symptoms of ileus include:
- Loss of appetite
- Abdominal cramping
- Constipation
- Feeling full
- Abdominal swelling
- Not being able to pass gas
- Vomiting, especially vomiting contents which are stool-like
- Nausea
Can Weight Loss Drugs Like Ozempic Cause Gallbladder Problems?
The diabetes drug Ozempic is used to control blood sugar levels and treat diabetes. However, it has been linked by multiple scientific studies with an increased risk of gallbladder issues:
- A 2016 study found that the use of glucagon-like peptide 1 (GLP-1) analogues is associated with a higher risk of gallbladder disease. Ozempic is a GLP-1 analogue. GLP-1 analogues are also known as GLP-1 receptor agonists.
- A 2017 study found that the use of GLP-1 receptor agonists is associated with a higher risk of developing cholelithiasis, or gallstones.
- A 2020 meta-analysis found that GLP-1 receptor agonists “significantly” increase the risk of developing cholelithiasis.
- A 2022 meta-analysis found that GLP-1 receptor agonists are associated with a higher risk of gallbladder diseases, especially when used for weight loss, for longer durations and at higher doses.
In addition, over 13,000 adverse events have been reported regarding Ozempic to the FDA Adverse Events Reporting System (FAERS). These events, as of May 7, 2023, included 86 cases of cholelithiasis and 40 cases of cholecystitis. These events were considered serious adverse events. Four patients had to discontinue use of Ozempic due to four acute gallbladder events.
In addition, cholelithiasis was reported in Ozempic clinical trials, according to Ozempic’s label. The condition was seen in 1.5 percent of patients given 0.5 mg of Ozempic and 0.4 percent of patients given 1 mg of Ozempic. The condition was not seen in patients given placebos in the clinical trials.
What Is Cholelithiasis?
Cholelithiasis, or gallstones, are digestive fluid deposits which harden in your gallbladder. Your gallbladder is an organ which is just underneath your liver. Gallstones typically form in one of three ways:
- Crystals can form when the liver makes more cholesterol than the amount which can be dissolved by bile, and these crystals can grow, forming stones.
- The liver can make too much of a yellow pigment known as bilirubin. This pigment is secreted into bile and can cause the formation of gallstones.
- Bile can form gallstones after becoming concentrated when the gallbladder fails to empty effectively.
The symptoms and complications of cholelithiasis include:
- Pain in the upper-right abdomen
- Pain between the shoulder blades
- Pain below the right shoulder
- Nausea
- Vomiting
- Fever
- Jaundice
- Itching
- Small bowel obstruction (gallstone ileus)
- Inflammation of the bile duct (ascending cholangitis)
- Acute pancreatitis
- Gallbladder cancer
What Is Cholecystitis?
Gallbladder inflammation is known as cholecystitis.
Cholecystitis is most commonly caused by gallstones which block the cystic duct, causing bile and pressure to build up in the gallbladder. It can also occur when tumors or bile duct scarring block the cystic duct.
The symptoms and complications of cholecystitis include:
- Pain in the upper-right abdomen
- Pain between the shoulder blades
- Pain below the right shoulder
- Nausea
- Vomiting
- Fever
- Jaundice
- Localized tenderness
- Shock
- Gangrene
- Gallbladder rupture
- Rokitansky-Aschoff sinuses
- Fistula formation
- Gallstone ileus
- Empyema
Ozempic, Pulmonary Embolism And Deep Vein Thrombosis
There is evidence that semaglutide, the active ingredient in Ozempic, may be linked with blood clots. A 2021 study found that those who took semaglutide were 3.66 times more likely to develop deep vein thrombosis, a type of blood clot.
A deep vein thrombosis is when a blot clot forms in a vein which is deep inside the body, typically in a leg.
The symptoms of deep vein thrombosis include:
- Swelling of the leg
- Leg soreness, cramping or pain which often begins in the calf
- The leg’s skin changing color – often purple or red
- The leg feeling warm
A deep vein thrombosis is potentially serious since a blood clot in a vein may break loose, traveling through the bloodstream into the lungs, where it gets stuck, becoming a pulmonary embolism.
Pulmonary embolisms can be life-threatening as they block the flow of blood to the lungs.
The primary symptoms of pulmonary embolism are:
- Fainting
- Chest pain
- Shortness of breath
Additional symptoms of pulmonary embolism include:
- Irregular or rapid heartbeat
- Coughing up blood
- Excessive sweating
- Dizziness or lightheadedness
- Leg swelling or pain, typically in the lower leg’s back
- Fever
- Discolored or clammy skin
If you have suffered a pulmonary embolism or deep vein thrombosis after taking Ozempic, you may qualify for financial compensation in an Ozempic lawsuit. Call us today for a free consultation.
Ozempic And Pulmonary Aspiration
Concerns have been raised in multiple medical journals, including Cureus, Canadian Journal of Anaesthesia and Plastic and Reconstructive Surgery-Global Open, that because semaglutide, the active ingredient in Ozempic, causes delayed gastric emptying, it may increase the risk of pulmonary aspiration occurring during surgery.
Pulmonary aspiration is when liquid, food or another material enters someone’s lungs. Pulmonary aspiration can lead to pneumonia, chronic scarring of the lungs and even death.
Call us today for a free consultation if you or a loved one suffered from pulmonary aspiration after taking Ozempic. We can help you recover financial compensation for your injury.
Ozempic And Pancreatic Cancer
A 2011 study found that patients taking GLP-1 agonists reported pancreatitis more often than those taking other therapies, raising concerns that the medications may cause pancreatic cancer.
Call us today for a free consultation if you or a loved one developed pancreatic cancer after taking Ozempic. You may be eligible for financial compensation in an Ozempic lawsuit.
Is Using Ozempic To Lose Weight Dangerous?
The U.S. Food and Drug Administration hasn’t approved Ozempic for the purpose of weight loss, and the official website for the drug notes that the medication is not a weight loss medication.
Ozempic has not undergone systematic testing as a weight loss drug. Because of this, it is not clear how damaging side effects from using Ozempic to promote weight loss might be.
Ozempic Lawsuit Updates
April 16, 2024 Update
According to a new report by The Daily Mail, weight loss medications such as Ozempic have been linked with over 100 United States deaths.
The report states that the FDA has received 117 reports of incidents involving deaths regarding those taking GLP-1 RA drugs such as Ozempic, Mounjaro and Wegovy. Included in the reports was a pregnant woman and a 28-year-old woman who ended up developing an intestinal mass.
81 of the reports were linked with semaglutide, Ozempic's active ingredient.
The FDA has also received reports of pancreatic cancer and seizures.
In other news, a woman filed a lawsuit in Iowa in April 5 alleging that she has suffered permanent, severe injuries after using the GLP-RA drug Trulicity. The woman alleges she has suffered extreme abdominal pain, diarrhea and persistent vomiting, and has had to visit the emergency room numerous times.
The lawsuit alleges she has developed permanent stomach paralysis, alleging that Eli Lilly knew or should have known that Trulicity could cause gastroparesis but failed to warn about this risk.
April 9, 2024 Update
A lawsuit filed in Pennsylvania by a Texas woman on March 26 alleges the woman needed a gallbladder removal and suffered additional serious gastrointestinal issues after taking Ozempic, which was prescribed to her by doctor for weight loss.
The lawsuit alleges Novo Nordisk didn't provide sufficient warnings regarding the serious nature of side effects associated with Ozempic.
The lawsuit claims the woman developed vomiting and severe nausea after taking Ozempic, and was diagnosed with gastritis, which she was eventually hospitalized for. When she was hospitalized, the lawsuit claims she was diagnosed with uncontrolled vomiting and a hiatial hernia.
Several months later, the lawsuit claims, the woman needed a gallbladder removal after being diagnosed with inflammation of her gallbladder.
April 4, 2024 Update
There were 74 cases pending in the Ozempic MDL on April 1, 2024.
March 17, 2024 Update
A hearing was held on March 13 in the Ozempic MDL. The hearing was regarding how cases should end up proceedings.
Dozens of plaintiffs are claiming that they didn't receive any warnings about possible dangers associated with Ozempic.
It is believed 10,000 or more cases could end up being filed in the MDL.
The MDL is being handled in Philadelphia, Pennsylvania because it's close to the headquarters of Novo Nordisk, which is located in New Jersey.
March 9, 2024 Update
A lawsuit filed in Pennsylvania alleges that a Pennsylvania woman developed gastroparesis after taking Ozempic and Trulicity. The lawsuit alleges the woman suffered painful, severe injuries, including severe nausea and bowel obstruction. The lawsuit claims the woman required multiple visits to the emergency room due to the gastroparesis. The lawsuit alleges that the manufacturer of the drugs, Novo Nordisk, knew that the drugs could cause gastroparesis for many years but failed to adequately warn healthcare providers and patients.
February 26, 2024 Update
A New York woman has filed a lawsuit against Eli Lilly, alleging that she developed severe sepsis, intestinal obstructions and additional complications, necessitating multiple surgeries and leaving her with permanent injuries, as a result of taking Mounjaro. The lawsuit alleges that Eli Lilly failed to adequately warn the medical community or users that Mounjaro might cause gastroparesis, or stomach paralysis. The lawsuit alleges the plaintiff suffered adhesions to the small intestines, a high-grade large bowel obstruction, severe sepsis and toxic megacolon, resulting in the necessity of emergency resection of her small and large intestines, in addition to a complete colectomy and the need for a colostomy bag.
February 23, 2023 Update
United States District Judge Gene E.K. Pratter, on February 15, issued a case management order which called for an initial status conference in the Ozempic MDL to be held on March 14. The judge indicated that the focus of the conference will be regarding how the MDL is conducted. The conference will cover the process of selecting lead counsel, the frequency and format of status conferences, how new filings are managed, a schedule regarding expected filings, and procedures for filings of motions.
February 19, 2024 Update
An Illinois woman has filed a lawsuit against Novo Nordisk alleging that Ozempic caused her to experience a blocked bowel as well as extreme vomiting and pain. The lawsuit alleges the woman's vomiting was so severe that she suffered a torn esophagus from it, requiring a week spent in the hospital.
The lawsuit is part of a batch of almost 60 lawsuits filed against the company, lawsuits which include allegations that a woman will have diarrhea for the rest of her life because of the drug, that a man required partial intestine removal due to the drug, and that a woman required gallbladder removal surgery due to the drug.
February 5, 2024 Update
A determination has been made by the U.S. Judicial Panel for Multidistrict Litigation (JPML): all stomach paralysis lawsuits involving GLP-1 receptor agonist drugs, such as Ozempic, Mounjaro, Wegovy, Rybelsus and Trulicity, will be consolidated in front of a single federal judge in Pennsylvania for a multidistrict litigation (MDL). U.S. District Judge Gene E.K. Pratter will oversee the MDL.
There are currently 18 GLP-1 receptor agonist lawsuits in federal court, but it is anticipated that hundreds or thousands of similar lawsuits will be filed in the future. The JPML noted that it has been estimated that almost 2 percent of the United States population has been prescribed a GLP-1 receptor agonist drug.
The lawsuits allege that the drugs can cause gastroparesis, or stomach paralysis, that their manufacturers knew or should have known about this risk, and that their manufacturers failed to warn about this risk.
January 24, 2024 Update
Reuters has reported that it is suspected that three United States cases of hypoglycemia, or blood sugar which is dangerously low, were caused by fake Ozempic.
According to America's Poison Centers, another person developed hypoglycemia after they injected a compounded version of the drug.
Last year, health authorities and Lebanon and Austria reported that many people developed hypoglycemia after they took Ozempic which was suspected to be fake - some of them were hospitalized.
A health regulator in Austria said those products probably contained insulin rather than semaglutide, the active ingredient in Ozempic. A drug regulator in Belgium confirmed that fake Ozempic which was seized in Belgium contained insulin.
January 19, 2024 Update
A federal judge has ruled that Novo Nordisk is subject to an injury lawsuit in Louisiana filed by a Louisiana woman regarding Ozempic. The judge ruled that the company’s connections to the state and linked closely enough to the claims of the plaintiff to support Louisiana jurisdiction. The woman alleges that Ozempic caused her to suffer from severe bouts of vomiting which caused her to lose teeth. The court ruled that Louisiana jurisdiction is supported by the company’s purposeful and voluntary contacts with the state. The court ruled that Novo Nordisk developed the drug, placing it into the marketplace expecting it to be sold in every state, including Louisiana.
January 9, 2024 Update
Novo Nordisk, in addition to plaintiffs, has asked a federal judge's panel to centralize and consolidate Ozempic and Wegovy stomach paralysis lawsuits before a single judge in a multidistrict litigation for pretrial proceedings and coordinated discovery. Over 40 complaints have been filed in federal court against the company and the makers of similar drugs, alleging that the GLP-1 receptor agonist drugs can cause side effects which were not warned about, such as gastroparesis. It is believed that thousands of claims are currently being investigated.
January 7, 2024 Update
The FDA has indicated that an investigation has been launched into possible increased risks of adverse side effects connected with Ozempic, Mounjaro, Wegovy and similar drugs, including suicide and hair loss. A recent quarterly report linked GLP-1 receptor agonist drugs to aspiration, alopecia, suicidal ideation and suicide.
December 27, 2023 Update
A lawsuit filed in Louisiana alleges that a woman suffered from gastroparesis, severe vomiting and diarrhea after using Ozempic. The woman allegedly needed multiple visits to the emergency room and required medication. The lawsuit alleges that the woman has been left with permanent, severe stomach paralysis which will require medical monitoring in the future. The lawsuit claims Novo Nordisk knew about or should have known about the risk of gastroparesis associated with Ozempic but failed to warn about it.
December 4, 2023 Update
Plaintiffs have asked United States judges to form a federal multidistrict litigation covering a growing number of lawsuits regarding gastroparesis (stomach paralysis) being caused by GLP-1 receptor agonist drugs such as Ozempic, Mounjaro and Wegovy. According to the plaintiffs' motion, while there are 18 cases currently pending in courts, attorneys are currently performing investigations into over 10,000 claims which might be filed in the future.
September 22, 2023 Update
The FDA has changed Ozempic's label to warn about the risk of ileus, which is when intestines can't normally contract to move waste through and out of the body.
What Should I Do If I Became Ill After Taking Ozempic?
If you suffered from gastroparesis, ileus, gallbladder disease or pulmonary embolism after taking Ozempic, you should:
- Acquire medical attention immediately if you are experiencing from painful or ongoing symptoms such as chronic stomach pain
- Have a talk with your doctor regarding your prescription and if you need to stop taking the drug or start with the use of an alternative
- Ask for copies of any relevant medical records from your healthcare provider – these records will be extremely useful when filing an Ozempic lawsuit later on
- Contact Nadrich Accident Injury Lawyers to talk with our Ozempic lawyers about what occurred
Call us today for a free case evaluation if you or a loved one developed ileus or gastroparesis after taking Ozempic. Our experienced dangerous drug lawyers, who have been representing victims of dangerous medications since 1990, can help you recover financial compensation for your medical bills, pain, suffering, lost wages and more in an Ozempic lawsuit.